256 related articles for article (PubMed ID: 29227110)
1. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
[TBL] [Abstract][Full Text] [Related]
2. Drug penetration and metabolism in 3D cell cultures treated in a 3D printed fluidic device: assessment of irinotecan via MALDI imaging mass spectrometry.
LaBonia GJ; Lockwood SY; Heller AA; Spence DM; Hummon AB
Proteomics; 2016 Jun; 16(11-12):1814-21. PubMed ID: 27198560
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry.
Liu X; Weaver EM; Hummon AB
Anal Chem; 2013 Jul; 85(13):6295-302. PubMed ID: 23724927
[TBL] [Abstract][Full Text] [Related]
4. A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids.
Markovitz-Bishitz Y; Tauber Y; Afrimzon E; Zurgil N; Sobolev M; Shafran Y; Deutsch A; Howitz S; Deutsch M
Biomaterials; 2010 Nov; 31(32):8436-44. PubMed ID: 20692698
[TBL] [Abstract][Full Text] [Related]
5. Single and Combination Drug Screening with Aqueous Biphasic Tumor Spheroids.
Shahi Thakuri P; Tavana H
SLAS Discov; 2017 Jun; 22(5):507-515. PubMed ID: 28324660
[TBL] [Abstract][Full Text] [Related]
6. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
Karlsson H; Fryknäs M; Larsson R; Nygren P
Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
[TBL] [Abstract][Full Text] [Related]
7. A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib.
Sargenti A; Musmeci F; Cavallo C; Mazzeschi M; Bonetti S; Pasqua S; Bacchi F; Filardo G; Gazzola D; Lauriola M; Santi S
PLoS One; 2021; 16(6):e0252907. PubMed ID: 34101765
[TBL] [Abstract][Full Text] [Related]
8. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
9. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
10. Robotic printing and drug testing of 384-well tumor spheroids.
Ham SL; Thakuri PS; Tavana H
Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Assessment of Anti-Cancer Drug Efficacy From Coregistered Mass Spectrometry and Fluorescence Microscopy Images of Multicellular Tumor Spheroids.
Michálek J; Štěpka K; Kozubek M; Navrátilová J; Pavlatovská B; Machálková M; Preisler J; Pruška A
Microsc Microanal; 2019 Dec; 25(6):1311-1322. PubMed ID: 31571549
[TBL] [Abstract][Full Text] [Related]
12. Acoustic Droplet-Assisted Superhydrophilic-Superhydrophobic Microarray Platform for High-Throughput Screening of Patient-Derived Tumor Spheroids.
Xia Y; Chen H; Li J; Hu H; Qian Q; He RX; Ding Z; Guo SS
ACS Appl Mater Interfaces; 2021 May; 13(20):23489-23501. PubMed ID: 33983701
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.
Sabhachandani P; Sarkar S; Mckenney S; Ravi D; Evens AM; Konry T
J Control Release; 2019 Feb; 295():21-30. PubMed ID: 30550941
[TBL] [Abstract][Full Text] [Related]
14. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
[TBL] [Abstract][Full Text] [Related]
15. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
16. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
[TBL] [Abstract][Full Text] [Related]
17. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
18. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
19. On-chip anticancer drug test of regular tumor spheroids formed in microwells by a distributive microchannel network.
Kim C; Bang JH; Kim YE; Lee SH; Kang JY
Lab Chip; 2012 Oct; 12(20):4135-42. PubMed ID: 22864534
[TBL] [Abstract][Full Text] [Related]
20. Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device.
Patra B; Peng CC; Liao WH; Lee CH; Tung YC
Sci Rep; 2016 Feb; 6():21061. PubMed ID: 26877244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
